TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Use of Text Messaging to Improve the Hospital-community Transition and Prevent Readmission in Patients With Cardiovascular Disease (Txt2Prevent)
Brief Summary: Participants will be recruited during their hospitalization for either heart attack or unstable angina and will be randomly assigned to either a text message program (Txt2Prevent) or usual care. They will be texted for the first 60-days after discharge. Texts will include topics regarding self-management and discharge protocols such as reminders to make an appointment with their general practitioner or to refill medication prescriptions. After 60 days, the two groups will be compared for hospital readmission rates, quality of life, medication adherence, and self-management.


Options:
A: Arm Label: SINEMA intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: SINEMA intervention | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: SINEMA intervention; Assigned to Arm(s): SINEMA intervention group
B: Arm Label: Text Message Group; Type: EXPERIMENTAL; Interventions: Behavioral: Text Message, Other: Website | Arm Label: Application Group; Type: EXPERIMENTAL; Interventions: Behavioral: Mobile Application, Other: Website | Arm Label: Website-Control; Type: EXPERIMENTAL; Interventions: Other: Website | Intervention Type: BEHAVIORAL; Name: Text Message; Assigned to Arm(s): Text Message Group | Intervention Type: BEHAVIORAL; Name: Mobile Application; Assigned to Arm(s): Application Group | Intervention Type: OTHER; Name: Website; Assigned to Arm(s): Application Group, Text Message Group, Website-Control
C: Arm Label: Intervention-Text messaging; Type: EXPERIMENTAL; Interventions: Behavioral: Text Messaging | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Text Messaging; Assigned to Arm(s): Intervention-Text messaging
D: Arm Label: Txt2Prevent; Type: EXPERIMENTAL; Interventions: Behavioral: Txt2Prevent | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Txt2Prevent; Assigned to Arm(s): Txt2Prevent

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Das Verhaltenstherapeutische Therapiemanual "Smoke_less" Zur Reduktion Des Tabakkonsums: Eine Evaluationsstudie Mit Ambulanten Patienten
Brief Summary: The aim of this study is to evaluate a new cognitive behavioral smoking reduction program for ambulant patients in a three-armed study design. Study participants will be randomized to one of the following three study groups: experimental group: 5-week lasting cognitive behavioral reduction program ("smoke_less"); active comparator: 15 minutes counseling interview; waiting group: no intervention.

The three follow-up measures take place after the reduction program in week 6, 17 an 29. After the finalisation of the last follow-up, participants from the active comparator and waiting group get the chance to take part at the smoking reduction program at no charge.


Options:
A: Arm Label: Smoking Reduction Program; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive behavioral smoking reduction program "Smoke_less" | Arm Label: Counseling Interview; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: 15 minute counseling interview | Arm Label: Waiting Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive behavioral smoking reduction program "Smoke_less"; Assigned to Arm(s): Smoking Reduction Program | Intervention Type: BEHAVIORAL; Name: 15 minute counseling interview; Assigned to Arm(s): Counseling Interview
B: Arm Label: Scheduled Gradual Reduction (SGR); Type: EXPERIMENTAL; Interventions: Behavioral: SGR, Behavioral: Support message only | Arm Label: Support Message Only; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Support message only | Intervention Type: BEHAVIORAL; Name: SGR; Assigned to Arm(s): Scheduled Gradual Reduction (SGR) | Intervention Type: BEHAVIORAL; Name: Support message only; Assigned to Arm(s): Scheduled Gradual Reduction (SGR), Support Message Only
C: Arm Label: Varenicline Tartrate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Varenicline Tartrate | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Varenicline Tartrate; Assigned to Arm(s): Varenicline Tartrate | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Less Dependent Smokers; Type: EXPERIMENTAL; Interventions: Drug: Nicotine Patch | Arm Label: More Dependent Smokers; Type: EXPERIMENTAL; Interventions: Drug: Nicotine Patch | Intervention Type: DRUG; Name: Nicotine Patch; Assigned to Arm(s): Less Dependent Smokers, More Dependent Smokers

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Growth Hormone Adjuvant Therapy With Long Down Regulation Protocol in Poor Responders Undergoing In Vitro Fertilization Cycles: a Randomized Control Trial
Brief Summary: The long down regulation protocol is widely used in the in vitro fertilization cycles, now it will be assessed regarding its efficacy, in poor responder females undergoing in vitro fertilization cycles, alone and after the addition of growth hormone.


Options:
A: Arm Label: The Long protocol; Type: EXPERIMENTAL; Interventions: Drug: Growth hormone (Norditropin, Novo nordisk) | Arm Label: The Short protocol; Type: EXPERIMENTAL; Interventions: Drug: Growth hormone (Norditropin, Novo nordisk) | Arm Label: The Antagonist protocol; Type: EXPERIMENTAL; Interventions: Drug: Growth hormone (Norditropin, Novo nordisk) | Arm Label: The Microflare protocol; Type: EXPERIMENTAL; Interventions: Drug: Growth hormone (Norditropin, Novo nordisk) | Intervention Type: DRUG; Name: Growth hormone (Norditropin, Novo nordisk); Assigned to Arm(s): The Antagonist protocol, The Long protocol, The Microflare protocol, The Short protocol
B: Arm Label: Long + Growth hormone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Growth hormone | Arm Label: Long protocol only; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Growth hormone; Assigned to Arm(s): Long + Growth hormone
C: Arm Label: Microflare and growth hormone; Type: EXPERIMENTAL; Interventions: Drug: Growth hormone (Norditropin, Novo nordisk) | Arm Label: Microflare protocol alone; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Growth hormone (Norditropin, Novo nordisk); Assigned to Arm(s): Microflare and growth hormone
D: Arm Label: Antagonist and Growth hormone; Type: EXPERIMENTAL; Interventions: Drug: Growth Hormone | Arm Label: Antagonist; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Growth Hormone; Assigned to Arm(s): Antagonist and Growth hormone

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Psycho-Social Well Being Following Stroke - A Randomized Controlled Trial
Brief Summary: Multicenter randomized controlled trial (RCT) testing the effect of a dialogue-based psychosocial intervention for stroke acute survivors in primary care one to six months poststroke. Primary outcome is psycho-social health and wellbeing, measured by GHQ28 (primary outcome) and SAQoL (secondary outcome). 400 stroke survivors are randomized into intervention group or control group. Patients are followed up for 12 months.


Options:
A: Arm Label: Recovering Together; Type: EXPERIMENTAL; Interventions: Behavioral: Recovering Together | Arm Label: Health Education; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Recovering Together; Assigned to Arm(s): Recovering Together
B: Arm Label: active rTMS treatment; Type: EXPERIMENTAL; Interventions: Device: active rTMS treatment | Arm Label: sham rTMS treatment; Type: SHAM_COMPARATOR; Interventions: Device: sham rTMS treatment | Intervention Type: DEVICE; Name: active rTMS treatment; Assigned to Arm(s): active rTMS treatment | Intervention Type: DEVICE; Name: sham rTMS treatment; Assigned to Arm(s): sham rTMS treatment
C: Arm Label: escitalopram; Type: EXPERIMENTAL; Interventions: Drug: Escitalopram | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: sugar pill | Intervention Type: DRUG; Name: Escitalopram; Assigned to Arm(s): escitalopram | Intervention Type: DRUG; Name: sugar pill; Assigned to Arm(s): placebo
D: Arm Label: Dialogue-based psychosocial intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Dialogue-based psychosocial rehabilitation | Arm Label: Usual care Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Dialogue-based psychosocial rehabilitation; Assigned to Arm(s): Dialogue-based psychosocial intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Psycho-Social Well Being Following Stroke - A Randomized Controlled Trial
Brief Summary: Multicenter randomized controlled trial (RCT) testing the effect of a dialogue-based psychosocial intervention for stroke acute survivors in primary care one to six months poststroke. Primary outcome is psycho-social health and wellbeing, measured by GHQ28 (primary outcome) and SAQoL (secondary outcome). 400 stroke survivors are randomized into intervention group or control group. Patients are followed up for 12 months.


Options:
A: N/A
B: Arm Label: Dialogue-based psychosocial intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Dialogue-based psychosocial rehabilitation | Arm Label: Usual care Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Dialogue-based psychosocial rehabilitation; Assigned to Arm(s): Dialogue-based psychosocial intervention
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: fluoxetine | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: fluoxetine; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 2
D: Arm Label: In-person behavioral intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Brief pleasurable events/behavioral therapy | Arm Label: Telephone behavioral intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Brief pleasurable events/behavioral therapy | Arm Label: Standard care; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard care | Intervention Type: BEHAVIORAL; Name: Brief pleasurable events/behavioral therapy; Assigned to Arm(s): In-person behavioral intervention, Telephone behavioral intervention | Intervention Type: OTHER; Name: Standard care; Assigned to Arm(s): Standard care

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of an Integrated E-learning Intervention, Focused on Comprehensive Geriatric Assessment to Improve the Quality of Drug Prescribing in Hospitalized Elderly Patients
Brief Summary: This randomized controlled pragmatic study is aimed to set-up, assess and implement an integrated e-learning program of medical education in an hospital setting, focused on teaching and implementing CGA added to geriatric pharmacological notions (GPNs) to improve the quality of drug prescribing in elderly patients


Options:
A: Arm Label: OSS Phase 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Training and supervision, Behavioral: Integrated Management of Infectious Disease (IMID) | Arm Label: OSS Phase 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Training and Supervision, Behavioral: Integrated Management of Infectious Disease (IMID) | Intervention Type: BEHAVIORAL; Name: Training and supervision; Assigned to Arm(s): OSS Phase 1 | Intervention Type: BEHAVIORAL; Name: Training and Supervision; Assigned to Arm(s): OSS Phase 2 | Intervention Type: BEHAVIORAL; Name: Integrated Management of Infectious Disease (IMID); Assigned to Arm(s): OSS Phase 1 | Intervention Type: BEHAVIORAL; Name: Integrated Management of Infectious Disease (IMID); Assigned to Arm(s): OSS Phase 2
B: Arm Label: E-learning program; Type: N/A; Interventions: Other: E-learning program | Arm Label: control group; Type: N/A; Interventions: N/A | Intervention Type: OTHER; Name: E-learning program; Assigned to Arm(s): E-learning program
C: Arm Label: Intervention; Type: OTHER; Interventions: Other: E-learning | Arm Label: Control; Type: OTHER; Interventions: Other: E-learning | Intervention Type: OTHER; Name: E-learning; Assigned to Arm(s): Control, Intervention
D: Intervention Type: BEHAVIORAL; Name: knowledge-adaptive Web-based instruction; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of an Integrated E-learning Intervention, Focused on Comprehensive Geriatric Assessment to Improve the Quality of Drug Prescribing in Hospitalized Elderly Patients
Brief Summary: This randomized controlled pragmatic study is aimed to set-up, assess and implement an integrated e-learning program of medical education in an hospital setting, focused on teaching and implementing CGA added to geriatric pharmacological notions (GPNs) to improve the quality of drug prescribing in elderly patients


Options:
A: Arm Label: Multi-PAP intervention; Type: EXPERIMENTAL; Interventions: Other: Multi-PAP, Other: Usual care | Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual care | Intervention Type: OTHER; Name: Multi-PAP; Assigned to Arm(s): Multi-PAP intervention | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Multi-PAP intervention, Usual care
B: Arm Label: naive Deprescribing arm; Type: EXPERIMENTAL; Interventions: Other: Team-care deprescribing with deprescribing guide | Arm Label: naive Wait-list Control arm; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: non-naive Deprescribing arm; Type: EXPERIMENTAL; Interventions: Other: Team-care deprescribing with deprescribing guide | Arm Label: non-naive Wait-list Control arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Team-care deprescribing with deprescribing guide; Assigned to Arm(s): naive Deprescribing arm, non-naive Deprescribing arm
C: Arm Label: Intervention; Type: OTHER; Interventions: Other: E-learning | Arm Label: Control; Type: OTHER; Interventions: Other: E-learning | Intervention Type: OTHER; Name: E-learning; Assigned to Arm(s): Control, Intervention
D: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Communication, Behavioral: Systematic Pain Assessment and Treatment, Behavioral: Medication Review, Behavioral: Occupational therapy, Behavioral: Safety | Intervention Type: BEHAVIORAL; Name: Communication; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Systematic Pain Assessment and Treatment; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Medication Review; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Occupational therapy; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Safety; Assigned to Arm(s): Intervention

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of an Integrated E-learning Intervention, Focused on Comprehensive Geriatric Assessment to Improve the Quality of Drug Prescribing in Hospitalized Elderly Patients
Brief Summary: This randomized controlled pragmatic study is aimed to set-up, assess and implement an integrated e-learning program of medical education in an hospital setting, focused on teaching and implementing CGA added to geriatric pharmacological notions (GPNs) to improve the quality of drug prescribing in elderly patients


Options:
A: Arm Label: Multidisciplinary medication review; Type: EXPERIMENTAL; Interventions: Procedure: Multidisciplinary medication review | Arm Label: usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Multidisciplinary medication review; Assigned to Arm(s): Multidisciplinary medication review
B: Arm Label: Optimization of drug prescribing; Type: EXPERIMENTAL; Interventions: Other: Optimization of drug prescribing | Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Optimization of drug prescribing; Assigned to Arm(s): Optimization of drug prescribing
C: Arm Label: Intervention; Type: OTHER; Interventions: Other: E-learning | Arm Label: Control; Type: OTHER; Interventions: Other: E-learning | Intervention Type: OTHER; Name: E-learning; Assigned to Arm(s): Control, Intervention
D: Arm Label: experimental group; Type: EXPERIMENTAL; Interventions: Other: tele-expertise | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: tele-expertise; Assigned to Arm(s): experimental group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of an Integrated E-learning Intervention, Focused on Comprehensive Geriatric Assessment to Improve the Quality of Drug Prescribing in Hospitalized Elderly Patients
Brief Summary: This randomized controlled pragmatic study is aimed to set-up, assess and implement an integrated e-learning program of medical education in an hospital setting, focused on teaching and implementing CGA added to geriatric pharmacological notions (GPNs) to improve the quality of drug prescribing in elderly patients


Options:
A: Arm Label: Patients without intervention; Type: ACTIVE_COMPARATOR; Interventions: Other: Clinical pharmacy model | Arm Label: Patients with intervention; Type: EXPERIMENTAL; Interventions: Other: Clinical pharmacy model | Intervention Type: OTHER; Name: Clinical pharmacy model; Assigned to Arm(s): Patients with intervention, Patients without intervention
B: Arm Label: Intervention; Type: OTHER; Interventions: Other: E-learning | Arm Label: Control; Type: OTHER; Interventions: Other: E-learning | Intervention Type: OTHER; Name: E-learning; Assigned to Arm(s): Control, Intervention
C: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Pharmacist Intervention for Low-Literacy in Cardiovascular Disease | Intervention Type: BEHAVIORAL; Name: Pharmacist Intervention for Low-Literacy in Cardiovascular Disease; Assigned to Arm(s): 2
D: Arm Label: SENATOR; Type: EXPERIMENTAL; Interventions: Other: SENATOR software generated pharmacotherapy advice report. | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: SENATOR software generated pharmacotherapy advice report.; Assigned to Arm(s): SENATOR

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Nasal High Frequency Oscillation Ventilation Versus Nasal Continuous Positive Airway Pressure to Reduce Post-extubation pCO2 in Very Low Birth Weight Infants: a Randomized Controlled Trial
Brief Summary: To investigate whether nasal high frequency oscillation ventilation (nHFOV) immediately after extubation reduces the arterial partial pressure of carbon dioxide (paCO2) at 72 hours after extubation in comparison with nasal continuous positive airway pressure (nCPAP) in very low birth weight infants (VLBWs).


Options:
A: Arm Label: BP-NCPAP; Type: ACTIVE_COMPARATOR; Interventions: Device: BP-NCPAP | Arm Label: NIHFV; Type: EXPERIMENTAL; Interventions: Device: NIHFV | Intervention Type: DEVICE; Name: BP-NCPAP; Assigned to Arm(s): BP-NCPAP | Intervention Type: DEVICE; Name: NIHFV; Assigned to Arm(s): NIHFV
B: Arm Label: nHFOV; Type: EXPERIMENTAL; Interventions: Device: nHFOV | Arm Label: nCPAP; Type: ACTIVE_COMPARATOR; Interventions: Device: nCPAP | Intervention Type: DEVICE; Name: nHFOV; Assigned to Arm(s): nHFOV | Intervention Type: DEVICE; Name: nCPAP; Assigned to Arm(s): nCPAP
C: Arm Label: NHFOV; Type: EXPERIMENTAL; Interventions: Device: NHFOV | Arm Label: NCPAP; Type: ACTIVE_COMPARATOR; Interventions: Device: NCPAP | Intervention Type: DEVICE; Name: NHFOV; Assigned to Arm(s): NHFOV | Intervention Type: DEVICE; Name: NCPAP; Assigned to Arm(s): NCPAP
D: Arm Label: nHFPV; Type: EXPERIMENTAL; Interventions: Procedure: Intrapulmonary Percussive Ventilation | Arm Label: nCPAP; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Nasal Continuous Positive Airway Pressure ventilation | Intervention Type: PROCEDURE; Name: Nasal Continuous Positive Airway Pressure ventilation; Assigned to Arm(s): nCPAP | Intervention Type: PROCEDURE; Name: Intrapulmonary Percussive Ventilation; Assigned to Arm(s): nHFPV

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Immediate Versus Interval Postpartum Use of the Levonorgestrel Contraceptive Implants: a Randomized Controlled Trial
Brief Summary: This study will evaluate if immediate postpartum placement of a levonorgestrel (LNG) contraceptive implant within 5 days of delivery improves implant utilization at 6 months postpartum compared to implant placement at 6-8 weeks postpartum among women in Uganda.


Options:
A: Arm Label: 6 weeks interval insertion; Type: OTHER; Interventions: Other: 6 weeks interval insertion | Arm Label: Immediate insertion; Type: EXPERIMENTAL; Interventions: Other: Immediate insertion | Intervention Type: OTHER; Name: Immediate insertion; Assigned to Arm(s): Immediate insertion | Intervention Type: OTHER; Name: 6 weeks interval insertion; Assigned to Arm(s): 6 weeks interval insertion
B: Arm Label: Levonorgestrel (LNG) implants immediately postpartum; Type: ACTIVE_COMPARATOR; Interventions: Device: Jadelle | Arm Label: Levonorgestrel (LNG) implants 6 weeks postpartum; Type: ACTIVE_COMPARATOR; Interventions: Device: Jadelle | Intervention Type: DEVICE; Name: Jadelle; Assigned to Arm(s): Levonorgestrel (LNG) implants immediately postpartum | Intervention Type: DEVICE; Name: Jadelle; Assigned to Arm(s): Levonorgestrel (LNG) implants 6 weeks postpartum
C: Arm Label: Immediate postpartum IUD insertion; Type: EXPERIMENTAL; Interventions: Device: Copper T380A Intrauterine Device | Arm Label: 6 week postpartum IUD insertion; Type: EXPERIMENTAL; Interventions: Device: Copper T380A Intrauterine Device | Intervention Type: DEVICE; Name: Copper T380A Intrauterine Device; Assigned to Arm(s): 6 week postpartum IUD insertion, Immediate postpartum IUD insertion
D: Arm Label: Postplacental IUD insertion; Type: EXPERIMENTAL; Interventions: Device: Levonorgestrel-releasing IUD (Mirena) | Arm Label: Delayed IUD insertion; Type: ACTIVE_COMPARATOR; Interventions: Device: Levonorgestrel-releasing IUD (Mirena) | Intervention Type: DEVICE; Name: Levonorgestrel-releasing IUD (Mirena); Assigned to Arm(s): Delayed IUD insertion, Postplacental IUD insertion

Answer: B